Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Pharmacy staff profile

Lucy Broughton

PositionPhD Student
QualificationsBPharm PGDipClinPharm PGCertPharm
Research summaryPsychotropic medicines in pregnancy
MembershipsPSNZ
ClinicalSenior Clinical Editor for NZ Formulary

Publications

Broughton, L. C., Medlicott, N. J., & Smith, A. J. (2021). Effectiveness of patient decision aids in women considering psychotropic medication use during pregnancy: A literature review. Archives of Women's Mental Health. Advance online publication. doi: 10.1007/s00737-021-01118-3

Glue, P., Neehoff, S., Sabadel, A., Broughton, L., Le Nedelec, M., Shadli, S., McNaughton, N., & Medlicott, N. J. (2020). Effects of ketamine in patients with treatment-refractory generalized anxiety and social anxiety disorders: Exploratory double-blind psychoactive-controlled replication study. Journal of Psychopharmacology, 34(3), 267-272. doi: 10.1177/0269881119874457

Le Nedelec, M., Glue, P., Winter, H., Goulton, C., Broughton, L., & Medlicott, N. (2018). Acute low-dose ketamine produces a rapid and robust increase in plasma BDNF without altering brain BDNF concentrations. Drug Delivery & Translational Research, 8(3), 780-786. doi: 10.1007/s13346-017-0476-2